Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, TDS, FVT

Brooks to Participate in Upcoming Investor Conferences


CHELMSFORD, Mass., Nov. 22, 2019 /PRNewswire/ -- Brooks Automation, Inc. (Nasdaq:BRKS) announced today that company management will participate in two upcoming investor conferences:

The live audio webcasts can be accessed through the Investor Relations page of the Brooks Automation website at www.brooks.com.  A replay of the presentations will be available following the events. 

About Brooks Automation
Brooks is a leading provider of life science and semiconductor manufacturing automation solutions worldwide.  The Company applies its automation and cryogenics expertise to provide a full suite of reliable cold-chain sample management solutions across life sciences in areas such as drug development, clinical research and advanced cell therapies.  Brooks recently added global capability for gene sequencing and gene synthesis services through its strategic acquisition of GENEWIZ, expanding its sample-based services offerings.  With over 40 years as a partner to the semiconductor manufacturing industry, Brooks is a provider of industry-leading precision robotics, integrated automation systems and services.  Brooks is headquartered in Chelmsford, MA, with operations in North America, Europe and Asia.  For more information, visit www.brooks.com.

INVESTOR CONTACTS:
Mark Namaroff
Director, Investor Relations
Brooks Automation
978.262.2635
mark.namaroff@brooks.com

Sherry Dinsmore
Brooks Automation
978.262.2400
sherry.dinsmore@brooks.com

John Mills
Senior Managing Director
ICR, LLC
646.277.1254
John.mills@icrinc.com

(PRNewsfoto/Brooks Automation)

SOURCE Brooks Automation


These press releases may also interest you

at 19:00
The "Diagnostic Imaging Services Market by Procedure (MRI, Ultrasound, X-RAY, CT, Nuclear Imaging (SPECT, PET), Mammography), Application (OB/Gyn, Orthopedics, Oncology, Vascular, Neurology), End User (Hospitals, Imaging Centers) - Global Forecast to...

at 18:49
The global market for EPA and DHA omega-3 ingredients is a 111,210 metric ton market valued at almost US$1.4 billion, and market dynamics vary by geographic region and end use product sector. GOED, the Global Organization for EPA and DHA Omega-3s,...

at 18:26
LI-COR Biosciences is pleased to announce that it has partnered with SciCrunch's Antibody Registry. This unique resource provides researchers with a way to universally identify antibodies used in their research. The Antibody Registry assigns...

at 18:00
3xLOGIC, Inc., a leading provider of integrated, intelligent security solutions, today announced its continuing support and sponsorship of Bolt for the Heart, which promotes several events that raise funds to place automated external defibrillators...

at 17:50
Prometheus Biosciences, Inc., ("Prometheus") a biopharmaceutical company committed to the discovery, development, and commercialization of a broad portfolio of novel precision therapeutics and companion diagnostics for patients living with unmet...

at 17:35
Cadent Therapeutics, a company focused on the development of therapies to improve the lives of patients with movement, mood, and cognitive disorders, today announced a poster presentation of its lead cognitive disorder asset CAD-9303, a positive...



News published on 22 november 2019 at 17:51 and distributed by: